Active Ingredient(s):Adalimumab-bwwd FDA Approved: * July 23, 2019 Pharm Company: *SAMSUNG BIOEPIS CO LTD Category:Immunosuppressive
Adalimumab, sold under the brand name Humira, among others, is a monoclonal antibody used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis.[5][6][7] It is administered by injection under the skin.[5]
Common side effects include upper respiratory tract infections, pain at the site o...
[wikipedia]
* May have multiple approval dates, manufacturers, or labelers.
